Nocion Therapeutics is a biopharmaceutical company developing novel small molecule CSCBs, nocions, that selectively affect actively firing nociceptors for the treatment of serious conditions involving cough, itch, and pain. The company's mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons.
Market
Pain management and sensory neuron-related conditions
Location
Watertown,
MA,
USA
Coinvestors
Arkin Bio Ventures, Canaan Partners, F-Prime Capital Partners, Mass General Brigham Ventures, Mission BioCapital, Monograph Capital, Osage University Partners